Stay updated on Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page.

Latest updates to the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for the UCART19 long-term follow-up trial is displayed, including its eligibility criteria, study design and outcomes, participating locations, and information about sharing study data.SummaryDifference47%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide banner announces changes to NIH website terminology, including a notice about using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, including a 403 header and a Home link, indicating access is blocked to the page.SummaryDifference0.5%

Stay in the know with updates to Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page.